Syngene International: Co MD Says Remain On Course To Deliver In Line With Our Stated Guidance For The Year 📈🗓️

 23 Jul 2025 03:20 PM

Syngene International: Co MD Says Remain On Course To Deliver In Line With Our Stated Guidance For The Year 📈🗓️

Syngene International: Co's Co MD Stresses Importance Of Being Aware Of Current Economic Conditions While Keeping A Positive Perspective. 📈

 23 Jul 2025 03:18 PM

Syngene International: Co's Co MD Stresses Importance Of Being Aware Of Current Economic Conditions While Keeping A Positive Perspective. 📈

SYNGENE INTERNATIONAL: Q1 EBITDA 2.1B RUPEES VS 1.7B (YOY) || Q1 EBITDA MARGIN 23.60% VS 21.5% (YOY)

 23 Jul 2025 03:01 PM

SYNGENE INTERNATIONAL: Q1 EBITDA 2.1B RUPEES VS 1.7B (YOY) || Q1 EBITDA MARGIN 23.60% VS 21.5% (YOY)

SYNGENE INTERNATIONAL: Q1 REVENUE 8.75B RUPEES VS 7.9B (YOY)

 23 Jul 2025 03:00 PM

SYNGENE INTERNATIONAL: Q1 REVENUE 8.75B RUPEES VS 7.9B (YOY)

SYNGENE INTERNATIONAL: Q1 CONS NET PROFIT 867M RUPEES VS 757M (YOY)

 23 Jul 2025 03:00 PM

SYNGENE INTERNATIONAL: Q1 CONS NET PROFIT 867M RUPEES VS 757M (YOY)

Tata Motors to Syngene- Prashanth Tapse suggests stocks to buy in the short term

 04 Jul 2025 12:38 PM

Indian stocks traded lower as investors awaited a trade agreement with the US and assessed SEBI's action against Jane Street. Nifty 50 rose 0.04% to 25,415.45, while Sensex increased 0.05%. Prashanth Tapse recommends buying Tata Motors, GRSE, Syngene, and Sigachi in the near-term.

Syngene International shares in focus after positive USFDA updates for 2 Bengaluru facilities

 16 Jun 2025 08:47 AM

Syngene International shares:The initial update concerns a Good Clinical Practices (GCP) compliance inspection carried out at Syngene’s Semicon Park facility in Bengaluru between June 9 and June 13, 2025. The inspection resulted in no findings, and no Form 483 was issued. It was classified as “No Action Indicated” (NAI), indicating full adherence to regulatory standards.

Syngene International: Company Obtains EIR From USFDA For Its GMP Manufacturing Facilities At Biocon Park, Bengaluru. 🏭

 13 Jun 2025 08:07 PM

Syngene International: Company Obtains EIR From USFDA For Its GMP Manufacturing Facilities At Biocon Park, Bengaluru. 🏭

Mutual funds bet big on healthcare stocks after Trump’s tariff pause. Is the danger really over?

 19 May 2025 09:17 AM

Following Trump's tariff pause in April 2025, the Nifty Healthcare index rebounded strongly, rising 7%. Mutual funds increased holdings in several healthcare stocks, with Syngene International seeing the highest buying. While some stocks like Zydus Lifesciences faced sell-offs, the sector's overall performance remained robust, outperforming the Nifty.

Stock futures with high rollover to May series on traders’ radar

 28 Apr 2025 05:51 AM

Several stocks, including Ultratech Cement and Mphasis, show bullish potential based on open interest and price changes, with analysts providing specific targets and stop losses. Conversely, Tata Steel and Syngene International face bearish outlooks due to technical resistance and disappointing earnings, respectively. Experts suggest trading strategies for both bullish and bearish stocks in the near term.